Stay updated on Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.

Latest updates to the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page
- Check2 days agoChange DetectedAdded Gūrgaon, India, 122001 and removed Gurgaon, India, 122001, reflecting a minor localization change in the site list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. The study details, contacts, locations, and other page content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check24 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 on the page, a minor metadata change with no visible content updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check31 days agoChange DetectedAdded a study site in Tainan, Taiwan and updated the location label from Tainan City, Taiwan to Tainan. Removed the generic government funding notice text from the page.SummaryDifference0.1%

- Check45 days agoChange DetectedThe study record's lifecycle statuses have been updated, adding Active, not recruiting; Withdrawn; Completed, and removing Not yet recruiting and Suspended. Key milestone dates were added or adjusted, including 2025-10-28, 2028-07-12, and 2030-10-01.SummaryDifference0.3%

- Check74 days agoChange DetectedUpgrade from Revision: v3.0.2 to v3.2.0, add government operating-status notice with new contact numbers; core content and access/operating status information updated.SummaryDifference2%

Stay in the know with updates to Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.